IQVIA Holdings (LTS:0JDM) Growth Rank: 9 (As of Aug. 21, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JDM IQVIA Holdings Inc LTS:0JDM
89 GF Score
Price $258.79
GF Value $249.85
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is IQVIA Holdings Growth Rank?

IQVIA Holdings LTS:0JDM +3.79% 89 Growth Rank is 9 as of Aug. 21, 2026, which is at its 10-year median of 9.00. GuruFocus rates LTS:0JDM with a GF Score™ of 89/100 and a GF Value™ of $249.85 (Fairly Valued). The stock has 8 warning signs investors should review.

IQVIA Holdings has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


IQVIA Holdings Growth Rank Related Terms


LTS:0JDM vs WAT, NTRA, A: Growth Rank Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings Growth Rank vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Growth Rank falls into.


LTS:0JDM
89GF Score
IQVIA Holdings Inc LTS:0JDM
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
IQVIA Holdings (LTS:0JDM) has a Growth Rank of 9 as of Aug. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on IQVIA Holdings and its competitors. This is near median its historical median of 9.00. Over the past decade, IQVIA Holdings' Growth Rank has ranged from 3.00 to 10.00.
Is IQVIA Holdings' Growth Rank too high?
IQVIA Holdings' current Growth Rank of 9 is near median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, IQVIA Holdings has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Growth Rank compare to WAT and NTRA?
IQVIA Holdings' Growth Rank of 9 can be compared against companies in the Medical Diagnostics & Research industry. Historically, IQVIA Holdings' own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Diagnostics & Research company?
A good Growth Rank depends on the Medical Diagnostics & Research industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Growth Rank is 9, which is near median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (LTS:0JDM) is currently considered Fairly Valued. The stock's GF Value™ is $249.85, compared to a current price of $258.79 — trading 3.6% above its estimated fair value. The current Growth Rank is 9, which is near median its 10-year median of 9.00. IQVIA Holdings' overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For IQVIA Holdings (LTS:0JDM), the current Growth Rank is 9 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (LTS:0JDM) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be overvalued. The current stock price of $258.79 is trading 3.6% above its estimated GF Value™ of $249.85. GuruFocus considers IQVIA Holdings to be Fairly Valued.

Key valuation signals for LTS:0JDM:

  • Growth Rank: 9 (near median its 10-year median of 9.00)
  • GF Value™: $249.85 vs. price of $258.79 (3.6% above fair value)
  • GF Score™: 89/100 with 8 warning signs

No single metric tells the full story. See the LTS:0JDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
89GF Score

Get the complete analysis for LTS:0JDM

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$258.79
Price
$249.85
GF Value